Abstract
Exposure to total body radiation results in dose dependent suppression of hematopoiesis (reviewed in 1–3). Variables influencing the extent of bone marrow suppression include total dose, dose rate, schedule, shielding, dose uniformity, as well as source-term parameters. Single-dose total body radiation at doses ≥ 1 Gy and dose rates ≥ 1 cGy per minute produce granulocytopenia and thrombocytopenia. Doses > 2 Gy can cause death from infection and bleeding. The 50% lethal dose (LD50) in humans is presumed to be 4–5 Gy based on data in animals. Higher radiation doses carry an increasing risk of death from bone marrow suppression; survival is unlikely after doses > 8–10 Gy. Doses > 15–20 Gy results in death from toxicity to other tissues such as the gastrointestinal tract or central nervous system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
UNSCEAR 1982. Ionizing radiation: sources and biologic effects. Report to the General Assembly, Vienna and New York.
Medical Research Council Committee on Effects of Ionizing Radiation. A forum on lethality from acute and protracted radiation exposure in man. Intl J Radiat Biol 1984; 46: 209–17.
Mettler FA Jr, Moseley RD Jr: Medical Effects of Ionizing Radiation. New York Grune and Stratton. 1985.
Gale RP. Immediate medical consequences of nuclear accidents: Lessons from Chernobyl. JAMA 1987; 258: 625–8.
Gale RP. The role of bone marrow transplantation following nuclear accidents. Bone Marrow Transplantation 1987; 2: 1–6.
Gale RP. The medical response to radiation and nuclear accidents: Lessons for the future. J Natl Cancer Inst Submitted
Gale RP, Reisner Y. Are bone marrow transplants effective after nuclear accidents? Lancet 1988; i:923–5.
Abramson S, Miller RG, Phillips RA. The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med 1977; 145: 1567–79.
Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 1986; 45: 917–27.
Roberts L. Radiation accident grips Goiania. Science. 1987; 238: 1028–31.
Golde DW, Takaku F (eds). Hematopoietic Stem Cells. New York, Marcel Dekker, Inc. 1985.
Wright DG, Greenberger JS (eds). Long-Term Bone Marrow Culture. New York, Alan R. Liss, Inc. 1984.
Metealf D. The molecular biology and functions of the granulocyte-marcophage colony-stimulating factors. Blood 1986; 67: 257–67.
Sieff CA. Hematopoietic growth factors. J Clin Invest 1987; 79: 1549–57.
Clark SC, Kamen R. The human hematopoietic colony stimulating factors. Science 1987; 236: 1229–37.
Donahue RE, Wange EA, Stone DK, et al. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Nature 1986; 321: 872–5.
Welte K, Platzer E, Lu L, et al. Purification and biological characterization of human pluripotent hematopoietic colony stimulating factor. Proc Natl Acad Sci 1985; 82: 1526–30.
Donahue RE, Seehra J, Norton C, et al. Hematologic effects of recombinant human interleukin-3 (rhIL-3) and granulocyte/ macrophage colony-stimulating factor (rhGM-CSF) in primates. Proceedings of ASCO, Vol 7, March 1988, p 162.
Groopman JE, Mitsuyasu RT, DeLeo JM, Oette DH, Golde DW. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 1987; 317: 593–8.
Brandt SJ, Peters WP, Atwater SK, et al. Effect of recombinant human granulocyte- macrophate colony-stimulating factor on hematopoietic reconstitution after high dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988; 318: 870–6.
Antman K, Griffin J, Elias A, et al. Use of rGM-CSF to ameliorate chemotherapy induced myelosuppression in sarcoma patients. Blood 1987; 70:Suppl 1: 129a.
Antin JH, Smith BR, Rosenthal DS, et al. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure. Blood 1987; 70:Suppl 1: 129a.
Morstyn G, Souza LM, Keech J, et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; i:667–71.
Butturini AB, De Souza PC, Gale RP, et al. Use of recombinant GM-CSF in the Brazil radiation accident. Submitted
Blazar BR, Widmer MB, Soderling, et al. Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte-macrophage colony-stimulating factor. Blood 1988; 71: 320–8.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this paper
Cite this paper
Gale, R.P., Butturini, A. (1989). The Role of Hematopoietic Growth Factors in Nuclear and Radiation Accidents. In: Baum, S.J., Dicke, K.A., Lotzová, E., Pluznik, D.H. (eds) Experimental Hematology Today—1988. Experimental Hematology Today—1988, vol 1988. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-8862-3_27
Download citation
DOI: https://doi.org/10.1007/978-1-4613-8862-3_27
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-8864-7
Online ISBN: 978-1-4613-8862-3
eBook Packages: Springer Book Archive